Cynosure Inc. (CYNO) Drops 5.86% on January 15

Equities Staff |

Cynosure Inc. (CYNO) was one of the Russell 2000's biggest losers for Friday January 15 as the stock slid 5.86% to $37.46, a loss of $-2.33 per share. Starting at an opening price of $38.85 a share, the stock traded between $37.19 and $39.63 over the course of the trading day. Volume was 192,753 shares over 1,956 trades, against an average daily volume of 208,041 shares and a total float of 22.73 million.

The losses send Cynosure Inc. down to a market cap of $851.31 million. In the last year, Cynosure Inc. has traded between $45.05 and $28.20, and its 50-day SMA is currently $40.40 and 200-day SMA is $36.53.

The stock has a P/E Ratio of 28.

Cynosure Inc develops & markets aesthetic treatment systems that enable plastic surgeons, dermatologists & other medical practitioners to perform non-invasive & minimally invasive procedures to remove hair, treat vascular & benign pigmented lesion, etc.

Cynosure Inc. is based out of Westford, MA and has some 755 employees. Its CEO is Michael R. Davin.

For a complete fundamental analysis analysis of Cynosure Inc., check out’s Stock Valuation Analysis report for CYNO. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

THC Therapeutics Inc

THC Therapeutics Inc is a health and healing company in the cannabis industry. The Company is engaged in developing dHydronator which is used to reduce moisture and effectively dry out…

Private Markets

Mesa-Marshall 2 Well Project

MESA Resources ("MESA") is sponsoring the development of the two well direct drilling project -- "Mesa-Marshall #1-2". MESA, founded in 1992, is engaged in the acquisition, exploration and development of…

CF0005, LLC dba Mesa-Marshall #1-2

MESA Resources, Inc. ("MESA") is sponsoring the development of the oil & gas well completion project "Mesa-Marshall #1-2". MESA, founded in 1992, is engaged in the acquisition, exploration and development…